Clifton Missy M, Johnson Sandra Marchese, Roberson Paula K, Kincannon Jay, Horn Thomas D
University of Arkansas for Medical Sciences Dermatology, Little Rock, Arkansas 72205-7101, USA.
Pediatr Dermatol. 2003 May-Jun;20(3):268-71. doi: 10.1046/j.1525-1470.2003.20318.x.
Intralesional injection of mumps and Candida skin test antigens has been shown to be effective in the treatment of warts. Warts are generally difficult to treat in children. To determine the efficacy of intralesional skin test antigen injection for the treatment of resistant warts in children, we treated 47 pediatric patients with one or more warts with intralesional injection of mumps or Candida skin test antigen into one wart. Twenty-two patients (47%) with resistant warts experienced complete resolution of treated warts. An average of 3.78 treatments were necessary. An additional 34% of children had a greater than 25% improvement in their warts. Sixty-eight percent of subjects with more than one wart also noted at least partial resolution (greater than 25% resolution) of untreated warts at distant sites, with 34% experiencing complete resolution. We concluded that intralesional injection of skin test antigens is an effective therapy for children who have recalcitrant, nongenital, cutaneous warts.
病灶内注射腮腺炎和念珠菌皮肤试验抗原已被证明对治疗疣有效。疣在儿童中通常难以治疗。为了确定病灶内注射皮肤试验抗原治疗儿童顽固性疣的疗效,我们对47例有一个或多个疣的儿科患者,在一个疣内病灶内注射腮腺炎或念珠菌皮肤试验抗原进行治疗。22例(47%)顽固性疣患者的治疗疣完全消退。平均需要3.78次治疗。另外34%的儿童疣有超过25%的改善。68%有多个疣的受试者还注意到远处未治疗的疣至少有部分消退(消退超过25%),其中34%完全消退。我们得出结论,病灶内注射皮肤试验抗原是治疗患有顽固性、非生殖器皮肤疣儿童的有效疗法。